William Martin's most recent trade in Immersion Corp was a trade of 68,400 Common Stock done at an average price of $7.9 . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.91 per share. | 01 Jul 2025 | 68,400 | 1,352,900 (4%) | 0% | 7.9 | 541,044 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 10,239 | 1,421,300 (4%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 5,968 | 1,411,061 (4%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.74 per share. | 01 Apr 2025 | 45,600 | 1,405,093 (4%) | 0% | 7.7 | 352,944 | Common Stock |
| Maravai LifeSciences Holdi... | William E. Martin | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 986,194 | 1,814,643 | - | - | Class A Common Stock | |
| Bancfirst Corp. | William Scott Martin | Director | Sale of securities on an exchange or to another person at price $ 119.13 per share. | 28 Feb 2025 | 10,000 | 214,499 (0%) | 0% | 119.1 | 1,191,255 | Common Stock |
| SB Financial Group Inc | William G. Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 1,024 | 16,617 (0%) | 0% | 0 | COMMON STOCK | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 86,899 | 1,423,543 (4%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 7.55 per share. | 31 Jan 2025 | 27,150 | 1,450,693 (4%) | 0% | 7.6 | 204,983 | Common Stock |
| Maravai LifeSciences Holdi... | William Martin E. | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 15 Jan 2025 | 160,981 | 828,449 | - | 4.6 | 734,073 | Class A Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.73 per share. | 01 Jan 2025 | 8,799 | 1,344,336 (4%) | 0% | 8.7 | 76,815 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.73 per share. | 01 Jan 2025 | 7,692 | 1,336,644 (4%) | 0% | 8.7 | 67,151 | Common Stock |
| Bancfirst Corp. | William Scott Martin | Director | Sale of securities on an exchange or to another person at price $ 124.70 per share. | 21 Nov 2024 | 24,607 | 224,499 (0%) | 0% | 124.7 | 3,068,481 | Common Stock |
| Bancfirst Corp. | William Scott Martin | Director | Sale of securities on an exchange or to another person at price $ 123.00 per share. | 15 Nov 2024 | 25,000 | 249,106 (0%) | 0% | 123.0 | 3,075,003 | Common Stock |
| Bancfirst Corp. | William Scott Martin | Director | Sale of securities on an exchange or to another person at price $ 123.17 per share. | 14 Nov 2024 | 7,500 | 274,106 (0%) | 0% | 123.2 | 923,759 | Common Stock |
| Bancfirst Corp. | William Scott Martin | Director | Sale of securities on an exchange or to another person at price $ 126.01 per share. | 13 Nov 2024 | 10,298 | 281,606 (0%) | 0% | 126.0 | 1,297,603 | Common Stock |
| Bancfirst Corp. | William Scott Martin | Director | Sale of securities on an exchange or to another person at price $ 117.00 per share. | 06 Nov 2024 | 15,000 | 291,904 (0%) | 0% | 117.0 | 1,754,964 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2024 | 6,672 | 1,353,135 (4%) | 0% | 0 | Common Stock | |
| Bancfirst Corp. | William Scott Martin | Director | Sale of securities on an exchange or to another person at price $ 113.50 per share. | 30 Oct 2024 | 5,000 | 306,904 (0%) | 0% | 113.5 | 567,500 | Common Stock |
| Maravai LifeSciences Holdi... | William Martin | Chief Executive Officer | 15 Oct 2024 | 50,843 | 989,430 | - | 8.3 | 421,488 | Class A Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.69 per share. | 01 Oct 2024 | 11,401 | 1,357,864 (4%) | 0% | 8.7 | 99,075 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.69 per share. | 01 Oct 2024 | 11,401 | 1,346,463 (4%) | 0% | 8.7 | 99,075 | Common Stock |
| Barnes & Noble Education Inc | William C. Martin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2024 | 20,430 | 145,871 (0%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 8.81 per share. | 27 Aug 2024 | 15,000 | 1,364,265 (4%) | 0% | 8.8 | 132,125 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 8.61 per share. | 27 Aug 2024 | 5,000 | 1,369,265 (4%) | 0% | 8.6 | 43,041 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 100,000 | 0 | - | - | Performance-based Restricted Stock Units | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 100,000 | 1,372,067 (4%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.23 per share. | 06 Aug 2024 | 22,802 | 1,349,265 (4%) | 0% | 10.2 | 233,264 | Common Stock |
| Bancfirst Corp. | William Scott Martin | Director | Sale of securities on an exchange or to another person at price $ 107.50 per share. | 25 Jul 2024 | 15,000 | 311,904 (0%) | 0% | 107.5 | 1,612,500 | Common Stock |
| Bancfirst Corp. | William Scott Martin | Director | Sale of securities on an exchange or to another person at price $ 107.50 per share. | 24 Jul 2024 | 5,000 | 326,904 (0%) | 0% | 107.5 | 537,501 | Common Stock |
| Barnes & Noble Education Inc | William C. Martin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.98 per share. | 08 Jul 2024 | 60,000 | 67,441 (0%) | 0% | 7.0 | 418,752 | Common Stock |
| Barnes & Noble Education Inc | William C. Martin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.19 per share. | 08 Jul 2024 | 38,000 | 125,441 (0%) | 0% | 7.2 | 273,182 | Common Stock |
| Barnes & Noble Education Inc | William C. Martin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.18 per share. | 08 Jul 2024 | 20,000 | 87,441 (0%) | 0% | 7.2 | 143,632 | Common Stock |
| Barnes & Noble Education Inc | William C. Martin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.19 per share. | 08 Jul 2024 | 12,000 | 12,000 (0%) | 0% | 7.2 | 86,268 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 150,000 | 1,272,067 (4%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 100,000 | 100,000 | - | - | Performance-based Restricted Stock Units | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 100,000 | 1,167,667 (3%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 53,678 | 1,079,067 (3%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.46 per share. | 28 Jun 2024 | 45,600 | 1,122,067 (3%) | 0% | 9.5 | 431,376 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.46 per share. | 28 Jun 2024 | 11,400 | 1,067,667 (3%) | 0% | 9.5 | 107,844 | Common Stock |
| Barnes & Noble Education Inc | William C. Martin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 7,441 | 7,441 (0%) | 0% | 0 | Common Stock | |
| Inozyme Pharma Inc | Martin William Edwards | Director | 18 Jun 2024 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | ||
| Morphic Holding Inc | Martin William Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,168 | 23,168 | - | - | Common Stock | |
| Charge Enterprises Inc | Paul Martin Williams | President, CEO Greenspeed | Other type of transaction at price $ 0.00 per share. | 03 May 2024 | 2,085,263 | 0 | - | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 35,565 | 1,025,389 (3%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 17,242 | 989,824 (3%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 100,000 | 983,265 (3%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.53 per share. | 29 Mar 2024 | 10,683 | 972,582 (3%) | 0% | 7.5 | 80,443 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 6,517 | 883,265 (2%) | 0% | 0 | Common Stock | |
| SB Financial Group Inc | Martin William G. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 1,528 | 14,201 (0%) | 0% | 0 | COMMON STOCK | |
| Maravai LifeSciences Holdi... | William Martin | Chief Executive Officer | 16 Jan 2024 | 758,415 | 1,040,273 | - | - | Class A Common Stock | ||
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 74,160 | 876,748 (2%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. | 29 Dec 2023 | 8,751 | 802,588 (2%) | 0% | 7.2 | 62,657 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 8,008 | 811,339 (2%) | 0% | 0 | Common Stock | |
| Bancfirst Corp. | Martin William Scott | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Dec 2023 | 1,500 | 331,904 (1%) | 0% | 0 | Common Stock | |
| Maravai LifeSciences Holdi... | William Martin | Chief Executive Officer | 21 Aug 2023 | 300,000 | 300,000 | - | - | Performance Stock Units | ||
| Charge Enterprises Inc | Paul Martin Williams | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 200,000 | 200,000 | - | - | Option, right to buy | |
| Charge Enterprises Inc | Paul Martin Williams | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 88,000 | 88,000 | - | - | Option, right to buy | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 14,834 | 818,949 (2%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.08 per share. | 30 Jun 2023 | 11,543 | 807,406 (2%) | 0% | 7.1 | 81,724 | Common Stock |
| Inozyme Pharma Inc | Martin William Edwards | Director | 13 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | ||
| Reata Pharmaceuticals Inc ... | Martin William Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 2,137 | 2,137 | - | - | Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Martin William Edwards | Director | Grant, award, or other acquisition of securities at price $ 93.61 per share. | 07 Jun 2023 | 1,682 | 6,116 (0%) | 0% | 93.6 | 157,452 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Martin William Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 169 | 169 | - | - | Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Martin William Edwards | Director | Grant, award, or other acquisition of securities at price $ 93.61 per share. | 07 Jun 2023 | 133 | 4,434 (0%) | 0% | 93.6 | 12,450 | Class A common stock |
| Morphic Holding Inc | Martin William Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,535 | 12,535 | - | - | Director Stock Option (Right to Buy) | |
| SB Financial Group Inc | William G. Martin | Director | Purchase of securities on an exchange or from another person at price $ 12.68 per share. | 09 May 2023 | 500 | 10,760 (0%) | 0% | 12.7 | 6,339 | COMMON STOCK |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.94 per share. | 01 Apr 2023 | 11,400 | 804,115 (2%) | 0% | 8.9 | 101,916 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 15,043 | 815,515 (2%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2023 | 100,000 | 843,176 (2%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.87 per share. | 19 Mar 2023 | 42,704 | 800,472 (2%) | 0% | 7.9 | 336,080 | Common Stock |
| SB Financial Group Inc | William G. Martin | Director | Purchase of securities on an exchange or from another person at price $ 14.25 per share. | 16 Mar 2023 | 1,000 | 10,260 (0%) | 0% | 14.3 | 14,250 | COMMON STOCK |
| SB Financial Group Inc | William G. Martin | Director | Grant, award, or other acquisition of securities at price $ 16.52 per share. | 03 Feb 2023 | 1,392 | 12,565 (0%) | 0% | 16.5 | 22,996 | COMMON STOCK |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 44,301 | 743,176 (2%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 6,342 | 698,875 (2%) | 0% | 0 | Common Stock | |
| Bancfirst Corp. | William Scott Martin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jan 2023 | 1,000 | 333,404 (1%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.03 per share. | 03 Jan 2023 | 8,751 | 692,533 (2%) | 0% | 7.0 | 61,520 | Common Stock |
| Maravai LifeSciences Holdi... | William Martin | See remarks | 17 Oct 2022 | 403,946 | 403,946 | - | - | Employee Stock Option (Right to Buy) | ||
| Maravai LifeSciences Holdi... | William Martin | See remarks | 17 Oct 2022 | 240,038 | 240,038 | - | - | Performance Stock Units | ||
| Maravai LifeSciences Holdi... | William Martin | See remarks | 17 Oct 2022 | 228,036 | 348,055 | - | - | Class A Common Stock | ||
| Maravai LifeSciences Holdi... | William Martin | See remarks | 17 Oct 2022 | 120,019 | 120,019 | - | - | Class A Common Stock | ||
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2022 | 14,346 | 701,284 (2%) | 0% | 0 | Common Stock | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.49 per share. | 01 Oct 2022 | 7,680 | 686,938 (2%) | 0% | 5.5 | 42,163 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.79 per share. | 13 Sep 2022 | 16,243 | 681,015 (2%) | 0% | 5.8 | 94,086 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.79 per share. | 13 Sep 2022 | 13,603 | 694,618 (2%) | 0% | 5.8 | 78,727 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.70 per share. | 01 Sep 2022 | 25,000 | 645,667 (2%) | 0% | 5.7 | 142,448 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.68 per share. | 01 Sep 2022 | 19,105 | 664,772 (2%) | 0% | 5.7 | 108,423 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.67 per share. | 01 Sep 2022 | 15,000 | 620,667 (1%) | 0% | 5.7 | 85,110 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.70 per share. | 30 Aug 2022 | 1,573 | 605,667 (1%) | 0% | 5.7 | 8,962 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.67 per share. | 25 Aug 2022 | 20,000 | 594,094 (1%) | 0% | 5.7 | 113,396 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.69 per share. | 25 Aug 2022 | 15,141 | 574,094 (1%) | 0% | 5.7 | 86,099 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.71 per share. | 25 Aug 2022 | 10,000 | 604,094 (1%) | 0% | 5.7 | 57,081 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.32 per share. | 18 Aug 2022 | 73,143 | 514,811 (1%) | 0% | 5.3 | 389,157 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.29 per share. | 18 Aug 2022 | 26,857 | 541,668 (1%) | 0% | 5.3 | 142,170 | Common Stock |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 5.35 per share. | 18 Aug 2022 | 17,285 | 558,953 (1%) | 0% | 5.4 | 92,549 | Common Stock |
| SB Financial Group Inc | William G. Martin | Director | Grant, award, or other acquisition of securities at price $ 16.85 per share. | 05 Aug 2022 | 1,000 | 10,700 (0%) | 0% | 16.9 | 16,850 | COMMON STOCK |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.36 per share. | 01 Jul 2022 | 7,680 | 441,668 (1%) | 0% | 5.4 | 41,165 | Common Stock |
| Inozyme Pharma Inc | Martin William Edwards | Director | 10 Jun 2022 | 9,367 | 9,367 | - | - | Stock Option (right to buy) | ||
| Reata Pharmaceuticals Inc ... | Martin William Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 5,620 | 5,620 | - | - | Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Martin William Edwards | Director | Grant, award, or other acquisition of securities at price $ 34.76 per share. | 08 Jun 2022 | 3,883 | 4,301 (0%) | 0% | 34.8 | 134,973 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Martin William Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 520 | 520 | - | - | Stock Option (right-to-buy) |